Acro Biomedical (ACBM) Other financing activities (2017 - 2025)
Acro Biomedical's quarterly Other financing activities came in at $2315.0 in Q4 2025, up 203.81% quarter-over-quarter from $762.0 in Q4 2019.
Acro Biomedical has reported Other financing activities for 3 years, with the latest figure at $2315.0 in Q4 2025.
- For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to $2315.0; the trailing twelve-month figure through Dec 2025 stood at $3077.0 (up 303.81% YoY), and the FY2025 full-year result was $4600.0, changed N/A from the prior year.
- Other financing activities for Q4 2025 stood at $2315.0, up from $762.0 in the prior quarter.
- The five-year high for Other financing activities was $2315.0 in Q4 2025, with the low at $2315.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,315.00 |
| Dec 31, 2025 | 2,315.00 |
| Dec 31, 2019 | 762.00 |
| Dec 31, 2019 | 762.00 |
| Dec 31, 2017 | -4,992.00 |
| Dec 31, 2017 | -4,992.00 |